TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2026
Back to search
Official data from USPTO
EVERY CURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVERY CURE
ST13
US500000097824413Class
35, 36, 42
Filing
97824413
Registration
8161744
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
04/24/2026
Trademark type
Word
Nice classes
35, 36, 42
Filing date
03/06/2023
Registration date
03/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2026
Last transaction
04/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-09-00
First use in commerce
2022-09-00
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA, US
Examiner
CLARK, MICHAEL J.
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EVERY CURE, INC.
EVERY CURE, INC.
Representatives
Scott W. Smilie PATZIK, FRANK & SAMOTNY LTD.
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Charitable servicespromoting public awareness of the need for access to pharmaceuticals; Charitable servicesnamely promoting public awareness of the need for equitable access to generic drugs for other diseases
Class 36
Charitable fundraising services
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical research; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; and using data to identify potential other uses for generic drugs; Charitable servicesconducting researchstudies and trials for others on alternative uses for pharmaceuticals
Publications
History of USPTO decisions and trademark events.
44 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/18/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/18/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/10/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/13/2026
IUAF
USE AMENDMENT FILED
01/13/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/12/2025
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2025
EX2G
SOU EXTENSION 2 GRANTED
08/11/2025
EXT2
SOU EXTENSION 2 FILED
08/11/2025
EEXT
SOU TEAS EXTENSION RECEIVED
08/11/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX1G
SOU EXTENSION 1 GRANTED
01/29/2025
EXT1
SOU EXTENSION 1 FILED
01/29/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/29/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/16/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2024
GNRT
NON-FINAL ACTION E-MAILED
05/10/2024
CNRT
NON-FINAL ACTION WRITTEN
05/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/04/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2023
GNRT
NON-FINAL ACTION E-MAILED
12/05/2023
CNRT
NON-FINAL ACTION WRITTEN
12/05/2023
DOCK
ASSIGNED TO EXAMINER
12/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2023
NWAP
NEW APPLICATION ENTERED
03/09/2023
Continuous trademark protection
Get notified about every new filing that threatens EVERY CURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.